Business Standard

Biofil Chemicals & Pharmaceuticals Share Price

Know More
BSENSE

69.45 0.50 (0.73%)

12:00 AM,18th May 2024

69.40-0.05 (-0.07%)

12:00 AM,18th May 2024

BSE : 524396

NSE : BIOFILCHEM

Sector : Health care

ISIN Code : INE829A01014

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 18-May-2024 | 12:00 AM IST

Market Cap (₹ Cr)

113

Turnover (₹ Cr)

0.00

Volume (Shares)

4

Face Value

10

52-WK High

78.80

52-WK High Date

01-Feb-2024

52-WK Low

41.01

52-WK Low Date

24-May-2023

All Time High

352.45

All Time High Date

14-Dec-2020

All Time Low

0.30

All Time Low Date

23-Nov-1998

Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products. Later on the Company was converted into a Public Limited Company on 7 May '92. The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug. It runs the business via two unit viz Pharmaceutical Division & Chemicals Division.In Feb.'96 the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively both aggregating Rs 23.21 cr to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations. The com...
Read More

Biofil Chemicals Announcement

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>BIOFIL CHEMICALS & PHARMACEUTICALS LTD.</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24233MP1985PLC002709</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Shweta Verma <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: bcplcompliance@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Pavan Singh Rajput <br/> Designation: Chief Financial Officer <br/> EmailId: pawan90rajkam@gmail.com</div> </div> <div> <br/> Date: 25/04/2024<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>BIOFIL CHEMICALS & PHARMACEUTICALS LTD.</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24233MP1985PLC002709</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. YES</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Shweta Verma <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: bcplcompliance@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Pavan Singh Rajput <br/> Designation: Chief Financial Officer <br/> EmailId: pawan90rajkam@gmail.com</div> </div> <div> <br/> Date: 25/04/2024<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

View More

Biofil Chemicals & Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

113

EPS - TTM (₹) [S]

0.41

P/E Ratio (X) [S]

6.39

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]10.86
P/B Ratio (₹) [S]6.39

Funds Owing this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)

Research Reports

Date Broker Action Prices(₹) Report
Data Not Found

Stock Strength

Today's Low/High

68.50

72.40

Week Low/High

65.70

72.00

Month Low/High

65.65

78.00

Year Low/High

41.30

79.00

All time Low/High

0.30

356.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week2.03%2.13%1.852.03%
1 Month1.46%1.09%2.092.30%
3 Month1.20%0.36%2.182.09%
6 Month41.66%42.07%12.4814.04%
1 Year60.02%59.17%20.4724.12%
3 Year-3.14%-3.07%47.4448.94%

Company Info

Company Information

Chairman & Managing Director : Ramesh Shah

Non Executive Director : Romil Shah

Independent Director : Shaila Jain

Independent Director : Satish Beohar

Independent Director : Ashok Kumar Ramawat

Whole-time Director : Ketan Shah

Company Sec. & Compli. Officer : Shweta Verma

Independent Director : Gayatri Padiyar

Registered Office: 11/12 Sector E Sanwer Road, Sanwer Road Industrial Area,Indore,Madhya Pradesh-452015 Ph: 91-731-2426700

Email:bcplcompliance@gmail.com; biofilchemicals@yahoo.co

URL:http://www.biofilgroup.net